Benzimidazoles as non-peptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 3: Discovery of 1-(1 H-benzimidazol-5-yl)-3- tert-butylurea derivatives

Abstract

1-(1 H-Benzimidazol-5-yl)-3- tert-butylurea derivatives have been identified as a novel class of non-peptide luteinizing hormone-releasing hormone (LHRH) antagonists. Herein, we disclose the synthesis and structure–activity relationships (SAR) of this class resulting in the identification of compound 12c, with dual functional activity on human and rat receptors (rat LHRH: IC 50 = 120 nM; human LHRH: IC 50 = 18 nM). These SAR studies suggest that 1-(1 H-benzimidazol-5-yl)-3- tert-butylurea is a new pharmacophore for small molecule LHRH antagonists.